Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology

C Domingues, A Santos, C Alvarez-Lorenzo… - ACS …, 2022 - ACS Publications
Worldwide nanotechnology development and application have fueled many scientific
advances, but technophilic expectations and technophobic demands must be …

Psychosocial and psychological interventions for treating postpartum depression

CL Dennis, ED Hodnett - Cochrane database of systematic …, 2007 - cochranelibrary.com
Background Postpartum depression is a major health issue for many women from diverse
cultures. While pharmacological interventions are an effective treatment for depression …

Do ultra-short screening instruments accurately detect depression in primary care?: A pooled analysis and meta-analysis of 22 studies

AJ Mitchell, JC Coyne - British Journal of General Practice, 2007 - bjgp.org
Background Guidance from the National Institute for Health and Clinical Excellence
recommends one or two questions as a possible screening method for depression. Ultra …

Why don't patients take their medicine? Reasons and solutions in psychiatry

AJ Mitchell, T Selmes - Advances in psychiatric treatment, 2007 - cambridge.org
Over the course of a year, about three-quarters of patients prescribed psychotropic
medication will discontinue, often coming to the decision themselves and without informing a …

Genetic differences in cytochrome P450 enzymes and antidepressant treatment response

K Hodgson, K Tansey, MZ Dernovšek… - Journal of …, 2014 - journals.sagepub.com
Aims: Antidepressant response varies between patients, possibly due to differences in the
rate cytochrome P450 enzymes metabolise antidepressants into inactive compounds. Drug …

Why and how people decide to stop taking prescribed psychiatric medication: exploring the subjective process of choice.

D Roe, H Goldblatt, V Baloush-Klienman… - Psychiatric …, 2009 - psycnet.apa.org
Objective: Despite the piling evidence supporting the effectiveness of psychiatric medication,
research has consistently shown that only about half of those administered treatment …

Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review

RB Trivedi, JA Nieuwsma, JW Williams - Journal of general internal …, 2011 - Springer
OBJECTIVE To examine the utility of psychotherapy in managing treatment resistant
depression. DATA SOURCES PubMed, PsycInfo, Embase, Cochrane Registry of Controlled …

The decision to continue or discontinue treatment: experiences and beliefs of users of selective serotonin-reuptake inhibitors in the initial months—a qualitative study

ECG Van Geffen, JHCM Hermsen, ER Heerdink… - Research in Social and …, 2011 - Elsevier
BACKGROUND: Little is known about patients' views on taking selective serotonin-reuptake
inhibitors (SSRIs) and their decision-making processes regarding either continuation or …

Cohort of one million patients initiating antidepressant treatment in France: 12‐month follow‐up

JP Fagot, A Cuerq, S Samson… - … journal of clinical …, 2016 - Wiley Online Library
Aims Previous studies have shown that the recommended minimum 6‐month period for
antidepressant treatment is actually observed for only a minority of patients. The objectives …

Agomelatine in standard medical practice in depressed patients: results of a 1-year multicentre observational study in France

P Gorwood, J Benichou, N Moore, M Wattez… - Clinical Drug …, 2020 - Springer
Abstract Background and Objectives Non-interventional studies are a valuable source of
evidence that is complementary to traditional randomised, blinded and controlled clinical …